Dyadic International (DYAI) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free DYAI Stock Alerts $1.49 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDyadic International files to sell 3.35M shares for holdersmsn.com - April 24 at 8:41 PMDYAI: Capital Raise to Accelerate Near Term Revenue Growthmsn.com - April 1 at 3:58 PMDyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcriptinsidermonkey.com - April 1 at 1:02 PMDyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 30 at 3:52 PMQ4 2023 Dyadic International Inc Earnings Callfinance.yahoo.com - March 29 at 8:25 AMRecap: Dyadic International Q4 Earningsbenzinga.com - March 28 at 5:22 PMDyadic Reports 2023 Full Year Results and Recent Company Progressglobenewswire.com - March 28 at 4:00 PMDyadic Announces Change in Board and Management Leadership Rolesglobenewswire.com - March 28 at 8:30 AMDyadic to Attend Industry Events in Aprilglobenewswire.com - March 27 at 8:30 AMDyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communicationsglobenewswire.com - March 26 at 8:30 AMDyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, Californiaglobenewswire.com - March 21 at 8:30 AMDyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024globenewswire.com - March 14 at 4:30 PMDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercializationfinance.yahoo.com - March 11 at 10:13 AMCORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercializationglobenewswire.com - March 11 at 9:57 AMDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercializationglobenewswire.com - March 11 at 8:30 AMDyadic to Attend Industry Events in Marchglobenewswire.com - March 1 at 8:30 AMDYAI Aug 2024 2.500 callca.finance.yahoo.com - February 29 at 1:39 AMDYAI Apr 2024 2.500 callca.finance.yahoo.com - February 29 at 1:39 AMDyadic announces strategic partnership agreement to develop rabies vaccinesmsn.com - February 28 at 10:37 AMDyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platformglobenewswire.com - February 28 at 8:30 AMDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutionsglobenewswire.com - February 23 at 2:00 AMDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutionsfinance.yahoo.com - February 21 at 1:17 PMDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutionsfinance.yahoo.com - February 21 at 1:17 PMDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutionsglobenewswire.com - February 21 at 8:30 AMDYAI: Catching Up With Dyadicfinance.yahoo.com - February 20 at 10:49 AMDyadic signs R&D agreement with global biopharmaceutical companymsn.com - February 6 at 4:14 PMDyadic to Attend BIO CEO & Investor Conference and European Industry Eventsfinance.yahoo.com - February 1 at 1:28 PMDyadic International, Inc Invites You to Join Us at The Microcap Conferencefinance.yahoo.com - January 22 at 4:31 PMDyadic International Inc DYAImorningstar.com - January 3 at 10:08 PMDyadic Attends Investor Events in Decemberfinance.yahoo.com - November 30 at 8:50 AMDyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidatefinance.yahoo.com - November 29 at 8:42 AMShareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years agofinance.yahoo.com - November 22 at 7:44 AMDyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africamarkets.businessinsider.com - November 20 at 12:47 PMDyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africafinance.yahoo.com - November 20 at 12:47 PMDyadic International’s Promising Outlook: COVID-19 Vaccine Progress, Strategic Collaborations, and Financial Stabilitymarkets.businessinsider.com - November 13 at 10:59 PMDYAI: Third Quarter Updatefinance.yahoo.com - November 9 at 6:51 PMDyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 9 at 6:51 PMRecap: Dyadic International Q3 Earningsbenzinga.com - November 8 at 7:57 PMDyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progressfinance.yahoo.com - November 8 at 7:57 PMDyadic International Inc (DYAI) Reports Decrease in Q3 Revenue and Net Loss Improvement ...finance.yahoo.com - November 8 at 7:57 PMDyadic to Present at Industry Events in Novemberfinance.yahoo.com - October 30 at 1:27 PMDyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023finance.yahoo.com - October 25 at 8:26 PMDYAI: Fall Updatefinance.yahoo.com - October 17 at 3:59 PMDyadic Appoints Doug Pace to Its Executive Leadership Teamfinance.yahoo.com - October 9 at 9:33 AMDyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseasesfinance.yahoo.com - October 5 at 1:09 PMDyadic to Present at Industry and Investor Events in Octoberfinance.yahoo.com - September 29 at 12:24 PMDyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using Dapibus™finance.yahoo.com - September 19 at 9:22 AMDyadic to Present at BioProcess Internationalfinance.yahoo.com - September 12 at 6:15 PMJupiter approves waterfront restaurant/office project (Photos)bizjournals.com - August 18 at 3:47 PMDYAI: MoUs Highlight C1 Vaccine Potentialfinance.yahoo.com - August 11 at 6:48 PM Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. DYAI Media Mentions By Week DYAI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DYAI News Sentiment▼0.590.32▲Average Medical News Sentiment DYAI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DYAI Articles This Week▼11▲DYAI Articles Average Week Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NKGen Biotech News SAB Biotherapeutics News OKYO Pharma News Cidara Therapeutics News Quince Therapeutics News Brainstorm Cell Therapeutics News Cyclo Therapeutics News Protara Therapeutics News IN8bio News AVROBIO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DYAI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
